The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Oncogene

• Publication date

  1995-09-07

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7545805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.

  1994cited by this paper
• T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.

  1994cited by this paper
• The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP

  1994cited by this paper
• The LIM domain: a new structural motif found in zinc-finger-like proteins.

  1994cited by this paper
• The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.

  1994cited by this paper
• BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets

  1993cited by this paper
• Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice.

  1993cited by this paper
• Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma

  1993cited by this paper
• T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes.

  1992cited by this paper
• The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development.

  1992cited by this paper
• Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma

  1992cited by this paper
• Transgenic models of tumor development.

  1991cited by this paper
• The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.

  1991cited by this paper
• TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11).

  1991cited by this paper
• T-cell translocation gene 1 (Ttg-1) encodes a nuclear protein normally expressed in neural lineage cells.

  1991cited by this paper
• An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs.

  1990cited by this paper
• A 3′ transcriptional enhancer regulates tissue‐specific expression of the human CD2 gene.

  1990cited by this paper
• The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif.

  1990cited by this paper
• LIM domains

  1990cited by this paper
• Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system

  1990cited by this paper
• Tissue‐specific control elements of the Thy‐1 gene.

  1990cited by this paper
• The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein

  1989cited by this paper
• Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice.

  1989cited by this paper
• CD2 expression in murine B cell lineage.

  1989cited by this paper
• The mechanism of chromosomal translocation t(11;14) involving the T‐cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15.

  1988cited by this paper
• The structure of the human CD2 gene and its expression in transgenic mice.

  1988cited by this paper
• Differential regulation of a Thy-1 gene in transgenic mice.

  1987cited by this paper
• Regulation of Thy-1 gene expression in transgenic mice.

  1987cited by this paper
• A lymphoproliferative abnormality associated with inappropriate expression of the Thy-1 antigen in transgenic mice.

  1987cited by this paper
• Mouse T cell antigen receptor: structure and organization of constant and joining gene segments encoding the beta polypeptide.

  1984cited by this paper
• Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

  1982cited by this paper
• Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

  1982cited by this paper

• Single-cell profiling reveals monocyte heterogeneity and association with liver fibrosis in patients with chronic HBV

  2025cites this paper
• LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

  2024cites this paper
• Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma

  2023cites this paper
• Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition

  2023cites this paper
• Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis

  2022cites this paper
• An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells

  2021cites this paper
• LMO2 is critical for early metastatic events in breast cancer

  2021cites this paper
• Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell Acute Lymphoblastic Leukemia.

  2020cites this paper
• Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model

  2019cites this paper
• Conditional Immortalization of Lymphoid Progenitors via Tetracycline-Regulated LMO2 Expression

  2019cites this paper
• Loss of CDKN2C accelerates progression of Notch-1 induced T lymphoblastic leukemia via activation of LMO2

  2017cites this paper
• Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes

  2016cites this paper
• LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration

  2016cites this paper
• Thymocytes self‐renewal: a major hope or a major threat?

  2016cites this paper
• LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia

  2016cites this paper
• The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity

  2015cites this paper
• Chromosomal Translocations and Gene Rearrangements in Acute Lymphoblastic Leukaemia

  2015cites this paper
• LMO2 at 25 years: a paradigm of chromosomal translocation proteins

  2015cites this paper
• Pre-clinical Modelling of Chromosomal Translocations and Inversions

  2015cites this paper
• The role of LMO4 in T cell acute lymphoblastic leukaemia

  2014cites this paper
• Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex

  2014cites this paper
• The role of LMO 4 in T cell acute lymphoblastic leukaemia by Eleni Georgiades

  2014cites this paper
• ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.

  2014cites this paper
• Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential

  2014cites this paper
• Epigenetic regulation of the Ink4a-Arf ( Cdkn2a ) tumor suppressor locus in the initiation and progression of Notch1 driven T-ALL

  2013cites this paper
• Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.

  2013cites this paper
• The Notch1-c-Myc Pathway Mediates Leukemia-Initiating Cell Activity in Mouse T-ALL Models: A Dissertation

  2013cites this paper
• Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non‐haematopoietic tumours using a newly developed rabbit monoclonal antibody

  2012cites this paper
• Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.

  2012cites this paper
• Identification of LMO 2 transcriptome and interactome in diffuse large B-cell lymphoma

  2012cites this paper
• Analyse de la régulation des réarrangements précoces du TCRδ dans la lymphopoïèse normale et les anomalies oncogéniques associées dans les leucémies aiguës lymphoblastiques T

  2012cites this paper
• B-cell lymphoma Identification of LMO2 transcriptome and interactome in diffuse large

  2012cites this paper
• T-cell receptor diversity prevents T-cell lymphoma development

  2012cites this paper
• Fonctions de l'oncoprotéine LMO2 déterminées par ses interactions protéiques

  2012influential citation
• LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era

  2012cites this paper
• Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.

  2011cites this paper
• IL-4 and TAL1 in T-cell acute lymphoblastic leukemia : studies on the participation of microenvironmental cues and cell-autonomous alterations in leukemogenesis

  2011cites this paper
• The Biology of Adult Acute Lymphoblastic Leukemia

  2011cites this paper
• Multipotent Progenitors Short-Term Hematopoietic Stem Cells and Indicates Lymphomyeloid Copriming in Gene Coexpression Analysis in Single Cells

  2010influential citation
• Gene Coexpression Analysis in Single Cells Indicates Lymphomyeloid Copriming in Short-Term Hematopoietic Stem Cells and Multipotent Progenitors

  2010influential citation
• A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients

  2010cites this paper
• The Chromosomal Translocation (11;14) (p13; q11) in Acute B-Cell Lymphocytic Leukemia

  2010cites this paper
• Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).

  2010influential citation
• The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal

  2010cites this paper
• Blocage de maturation thymique et aberration des recombinaisons V(D)J : modèle des Leucémies Aigües Lymphoblastiques de la lignée T exprimant les onco-protéines à homéodomaines TLX1 et TLX3

  2010cites this paper
• Mécanisme de leucémogénèse par les oncogènes SCL et LMO1

  2010cites this paper
• Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies.

  2009cites this paper
• Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.

  2009cites this paper
• Mechanisms of NOTCH1 Mediated Leukemogenesis: A Dissertation

  2009cites this paper
• An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions

  2008cites this paper
• Gene therapy for primary immunodeficiencies.

  2008cites this paper
• Rearrangements and amplification of the ABL1 gene as an example of kinase activation in T-cell acute lymphoblastic

  2008cites this paper
• Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

  2008cites this paper
• Resistance of mature T cells to oncogene transformation.

  2008cites this paper
• TLX1/HOX11-induced hematopoietic differentiation blockade

  2007cites this paper
• Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency 1

  2007cites this paper
• Gene therapy for severe combined immunodeficiency: are we there yet?

  2007cites this paper
• Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets

  2007cites this paper
• New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.

  2007cites this paper
• Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency.

  2007cites this paper
• Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice

  2007cites this paper
• p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.

  2007cites this paper
• Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy

  2007cites this paper
• A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.

  2007cites this paper
• Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency

  2007cites this paper
• Mechanisms of transcription factor deregulation in lymphoid cell transformation

  2007cites this paper
• Identification of the key LMO2-binding determinants on Ldb1.

  2006cites this paper
• Gene therapy: Therapeutic gene causing lymphoma

  2006cites this paper
• Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

  2006cites this paper
• The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.

  2006cites this paper
• Gene therapy for treatment of inherited haematological disorders

  2006cites this paper
• The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.

  2006cites this paper
• Genotoxicity of retroviral integration in hematopoietic cells.

  2006cites this paper
• LIM Domain and Its Binding to Target Proteins

  2005cites this paper
• Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia.

  2005cites this paper
• Mutagenèse insertionnelle et thérapie génique

  2005cites this paper
• Insertional mutagenesis and gene therapy

  2005cites this paper
• ANALYSIS OF Lyll EXPRESSION AS A FREQUENT PARTNER OF LMO2 IN T-CELL LEUKEMOGENESIS IN HUMAN

  2005cites this paper
• Analysis of Lyl1 expression as a frequent partner of LMO2 in T-cell leukemogenesis in human

  2005cites this paper
• Insertional oncogenesis in gene therapy: how much of a risk?

  2004cites this paper
• Mechanisms of TAL1 Induced Leukemia in Mice: A Dissertation

  2004cites this paper
• Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

  2004cites this paper
• SCL: from the origin of hematopoiesis to stem cells and leukemia.

  2004cites this paper
• Xenopus Xlmo4 is a GATA cofactor during ventral mesoderm formation and regulates Ldb1 availability at the dorsal mesoderm and the neural plate.

  2003cites this paper
• Occurrence of leukaemia following gene therapy of X-linked SCID

  2003cites this paper
• Occurrence of leukaemia following gene therapy of X-linked SCID

  2003cites this paper
• The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development

  2003cites this paper
• Chromosomal translocation master genes, mouse models and experimental therapeutics

  2001cites this paper
• T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity

  2001cites this paper
• Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice

  2001cites this paper
• The LIM domain: regulation by association.

  2000cites this paper
• Identification of genes potentially involved in LMO2-induced leukemogenesis

  2000cites this paper
• The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development.

  1999cites this paper
• Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice

  1999influential citation
• The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.

  1999cites this paper
• Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation—why are these functions targeted?

  1999cites this paper
• The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.

  1998cites this paper
• LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.

  1998cites this paper
• The oncogenic T cell LIM‐protein Lmo2 forms part of a DNA‐binding complex specifically in immature T cells

  1998cites this paper
• Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia

  1998cites this paper